CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

When to Start and Stop collecting Adverse Events

admin - 0
When to start and when to stop? Before answering this question, let’s understand where the confusion relies. Generally we start recording the adverse event just...

Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine

admin - 0
Jan 09, 2020: Almirall, a leading global pharmaceutical company focused on medical dermatology, and 23andMe, the leading consumer genetics and research company, have signed an...

Hikma and Arecor announce exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US using Arestat™ technology

admin - 0
Jan 09, 2020: Hikma Pharmaceuticals and Arecor new joint agreement is set to co-develop new, ready-to-use injectable medicine in the US through Hikma’s affiliate,...

Bayer and Exscientia collaborate to influence the potential of artificial intelligence(AI) in cardiovascular and oncology drug discovery

admin - 0
Jan 09, 2020: Bayer and Exscientia Ltd. entered into a three-year multi-target collaboration, will work on early research projects combining Exscientia’s proprietary AI drug...

FDA approves Blueprint Medicines Ayvakit (avapritinib) ,first targeted therapy to treat a rare mutation in patients with Unresectable or Metastatic PDGFRA Exon 18...

admin - 0
Jan 09, 2020: The U.S. Food and Drug Administration approved Blueprint Medicines, Ayvakit (avapritinib) for the treatment of adults with unresectable (unable to be...

Daiichi Sankyo ENHERTU® is Now Available in the U.S. for the HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based...

admin - 0
Jan 6, 2020: Daiichi Sankyo Company ltd announced that ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate, is now available by prescription in...

FDA approves less invasive surgical approach for Abbott’s heart pump in order to help patients avoid Open Heart Surgery

admin - 0
 Jan. 07, 2020: U.S. FDA approved Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery....

Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility does not improve pregnancy rates, sperm counts or sperm function

admin - 0
Jan 07, 2020: According to a study conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),Dietary supplements containing zinc and...

BMS Completes Divestment of its oral solid, biologics, and sterile product Manufacturing and packaging Facility in Anagni, Italy

admin - 0
JAN 07, 2020: Bristol-Myers Squibb Company announced that it has completed its previously announced divestment of its oral solid, biologics, and sterile product manufacturing and...

FDA Ok’s Teleflex for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

admin - 0
Jan. 07, 2020: Teleflex announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for the use of...

Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate

admin - 0
Jan 07, 2020: Valneva SE announced that the End Of Phase 2 (EOP2) meeting has been scheduled with the U.S. FDA on February 24,...

BAVENCIO (avelumab) extensively Improved Overall Survival in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

admin - 0
Jan 06, 2020: Merck and Pfizer Inc, announced the Phase III JAVELIN Bladder 100 study met its primary endpoint on the whole survival (OS)...
1...636465Page 64 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved